Chiho Ishida

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Koji Abe, Masashi Aoki, Shoji Tsuji et al. · The Lancet Neurology · 2017 · 900 citations

Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis, Neurological Disorder +6

Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus

Yuko Kato‐Motozaki, Kenjiro Ono, Keisuke Shima et al. · Journal of the Neurological Sciences · 2008 · 80 citations

Alzheimer's Disease, Neuroepidemiology, Dementia +8

Cybernic treatment with wearable cyborg Hybrid Assistive Limb (HAL) improves ambulatory function in patients with slowly progressive rare neuromuscular diseases: a multicentre, randomised, controlled crossover trial for efficacy and safety (NCY-3001)

Takashi Nakajima, Yoshiyuki Sankai, Shinjiro Takata et al. · Orphanet Journal of Rare Diseases · 2021 · 80 citations · Full text

Clinical features of non‐hypertensive lobar intracerebral hemorrhage related to cerebral amyloid angiopathy

Mie Hirohata, Mitsuhiro Yoshita, Chiho Ishida et al. · European Journal of Neurology · 2010 · 56 citations

A clinical phenotype of distal hereditary motor neuronopathy type II with a novel HSPB1 mutation

Yoshihisa Ikeda, Akiko Abe, Chiho Ishida et al. · Journal of the Neurological Sciences · 2008 · 48 citations

Novel Hspb1 Mutation, Mendelian Disorder, Genetic Disorder +9